Brain delivery of lipid nanoparticles with shuttle peptides.
Shuttle peptides just leveled up brain research. A new review in Advanced Pharmacology breaks down how these short peptide sequences are turning lipid nanoparticles (LNPs) into legit vehicles for crossing the blood-brain barrier (BBB). That’s a big deal if you’re working on CNS delivery challenges.
Adv Pharmacol
by Martinez-Martinez N, Carrera-Rodríguez L, Vargas R et al.
“Brain delivery of lipid nanoparticles with shuttle peptides. Martinez-Martinez N(1), Carrera-Rodríguez L(2), Vargas R(3), Hernández-Munain C(4), Suñé-Pou M(5), Suñé C(6). Author information: (1)Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain; Department of Molecular Biology, Institute of Parasitology and Biomedicine "López-Neyra" (IPBLN-CSIC), Granada, Spain. (2)Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain. (3)Department of Industrial Pharmacy, Faculty of Pharmacy, University of Costa Rica, San José, Costa Rica; Pharmaceutical Research Institute (INIFAR), Faculty of Pharmacy, University of Costa Rica, San José, Costa Rica. Electronic address: ronny.vargas_m@ucr.ac.cr. (4)Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine "López-Neyra" (IPBLN-CSIC), Granada, Spain. (5)Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain; Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Research Group Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain. Electronic address: marcsune@ub.edu. (6)Department of Molecular Biology, Institute of Parasitology and Biomedicine "López-Neyra" (IPBLN-CSIC), Granada, Spain. Lipid nanoparticles (LNPs) have gained growing attention as advanced drug delivery systems capable of addressing major challenges in the development of innovative therapies. They have been widely investigated to overcome the challenges of development delivery strategies for the Central Nervous System (CNS). Their small size, biomimetic lipid composition, and modifiable surface properties make them promising candidates for targeting the Blood Brain Barrier (BBB), leading to improved therapeutic interventions. This chapter provides an integrative overview of the main classes of LNPs and their manufacturing methods, offering insights into their design, characterization, and optimization for brain delivery. We first discuss the key physicochemical parameters -particle size, polydispersity index, surface charge, shape, crystallinity, and encapsulation efficiency- and their impact on biodistribution, stability, and BBB penetration. Formulation and manufacturing strategies are examined, from conventional approaches to microfluidic mixing. Special attention is given to surface modification strategies, including ligand conjugation and the technological variables influencing receptor-specific transport that determine brain targeting. We place particular emphasis on brain-shuttle peptides, which constitute the most widely employed approach for functionalizing LNPs. Finally, we summarize representative preclinical studies, emerging clinical trials, and key translational challenges -such as neurotoxicity, batch-to-batch reproducibility, and regulatory hurdles-, but also highlight the proved potential of LNPs to achieve successful clinical translation in other therapeutic areas. These advances provide valuable insights and technical precedents that may benefit the development of LNP-based therapeutics for CNS disorders, supporting future strategies targeting neurological and psychiatric disorders as well as brain tumors. Copyright © 2026. Published by Elsevier Inc.”
Here’s the play-by-play: LNPs are already hot in drug delivery, but getting compounds past the BBB is brutal. Most stuff just gets blocked. Shuttle peptides solve that. Researchers are attaching these peptides to the surface of LNPs, tricking the BBB into letting them through. The review outlines exactly how changes in particle size, charge, and surface shape affect this process.
Key takeaway: Functionalizing LNPs with brain-shuttle peptides is now the leading move for getting research compounds where you want them in the brain.
The review covers:
Different classes of LNPs and how they’re built
The science behind optimizing LNPs for stability and brain targeting
Real-world applications, from preclinical models to clinical trials
How to manage issues like neurotoxicity and reproducibility—without hitting panic mode
The authors don’t just list problems. They also point out successes, especially in other therapeutic areas, that set the stage for CNS breakthroughs. If you’re designing brain-targeted experiments or thinking about next-gen delivery systems, this is worth your time.
Want to go deeper on shuttle peptides and LNPs for brain delivery? Check out the peptide research index for more. If you're sourcing research compounds, our vendor directory has you covered.
Peptides aren’t just along for the ride—they’re driving brain research forward.
Related Reading
The STRIDE Trial and Semaglutide: Implications for Clinical Vascular Practice.
News · J Med ChemStructure-Based Adaptation of a SARS-CoV-2 Neutralizing Peptide to New Virus Variants.
News · J Nucl MedCombining an α(v)β(6)-Targeted (177)Lu-Based Peptide Receptor Radionuclide Therapy with Olaparib to Boost Therapeutic Efficacy in Pancreatic Cancer.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.